Glioma Types and Standard of Care

Gliomas are a type of brain tumor that originates from glial cells. These cells are part of the brain and spinal cord, playing a crucial role in supporting and protecting neurons, the primary cells responsible for transmitting signals throughout the nervous system.

How Are Gliomas Graded?

Unlike many other types of cancer, which are staged based on how far they have spread, gliomas are graded based on their microscopic appearance and biological behavior. This grading system helps doctors determine how aggressive the tumor is and how best to approach treatment.

Pathologists analyze glioma cells using several key factors:

• Cell Appearance: The more abnormal the tumor cells look, the higher the grade.
• Cell Division Rate: A higher number of actively dividing cells suggests faster tumor growth.
• Blood Vessel Formation: The presence of new blood vessels feeding the tumor indicates a more aggressive nature.
• Necrosis (Cell Death): The presence of dead tumor cells signals highly aggressive behavior.

Gliomas are classified into four grades:

1. Grade I (Low-Grade, Least Aggressive): These tumors grow slowly and are most common in children. An example is pilocytic astrocytoma. If completely removed with surgery, the prognosis is excellent, and additional treatment may not be necessary.
2. Grade II (Low-Grade but More Complex): These tumors also grow slowly but have the potential to evolve into higher-grade tumors over time. Surgery is the main treatment, but radiation or chemotherapy may be needed if complete removal is not possible or if signs of progression appear.
3. Grade II (High-Grade, More Aggressive): These tumors grow more rapidly and are considered malignant. Treatment typically includes a combination of surgery, radiation, and chemotherapy. While treatment can slow progression, recurrence is common.
4. Grade IV (Astrocytomas (IDH mutant) and Glioblastomas (IDH wildtype), Most Aggressive): These tumors grow very quickly and infiltrate surrounding brain tissue. The standard treatment includes surgery, radiation, and chemotherapy. Additionally, new experimental treatments and clinical trials may provide more options. While glioblastomas and astrocytomas are challenging to treat, ongoing research aims to improve survival and quality of life. Both are considered grade IV and aggressive but are extremely different in terms of response and survival.

How Are Gliomas Treated?

The treatment of gliomas depends on the tumor’s grade, location, size, and molecular characteristics. The primary treatment options include:

• Surgery: The first and most crucial step in treating gliomas is surgical removal. The goal is to remove as much of the tumor as possible while preserving brain function. In some cases, complete removal may not be feasible due to the tumor’s location.
• Radiation Therapy: High-energy beams, such as X-rays or protons, are used to destroy tumor cells and slow tumor growth. Radiation is often recommended for higher-grade gliomas or when surgery cannot remove all tumor tissue.
• Chemotherapy: Drugs like temozolomide (TMZ) are commonly used to target and kill rapidly growing tumor cells. Chemotherapy may be used alone or in combination with radiation
• Targeted Therapy: Certain molecular characteristics of gliomas can be targeted with specific drugs. For example, patients with IDH-mutant gliomas may be eligible for drugs like vorasidenib.
• Tumor-Treating Fields (TTF): A wearable device that delivers electrical fields to disrupt tumor cell division, often used for glioblastomas.
• Clinical Trials: Many patients explore clinical trials to access new treatments and innovative therapies that may not yet be widely available.
• Supportive and Palliative Care: Managing symptoms and maintaining quality of life are essential aspects of glioma treatment. Supportive care may include medications to control seizures, swelling, and pain, as well as rehabilitation therapies to improve function.

The Role of Molecular Markers in Treatment

Beyond grading, doctors now use molecular markers to better understand gliomas and personalize treatment plans. These genetic characteristics can help predict how a tumor may behave and how well it will respond to specific therapies.

Some key molecular markers include:

• Isocitrate Dehydrogenase (IDH) Mutation: Found in some grade II and III gliomas, this mutation is linked to better outcomes. Patients may benefit from targeted drugs like vorasidenib, which can help delay tumor progression.
• 1p/19q Co-Deletion: Found in oligodendrogliomas, this genetic alteration is associated with improved prognosis. Treatment often includes temozolomide and possibly PCV chemotherapy (procarbazine, lomustine, and vincristine).
• ATRX Mutation & TP53 Mutation: These markers help differentiate astrocytomas from other gliomas and inform classification.
• TERT Promoter Mutation: Common in glioblastomas, this mutation signals a more aggressive tumor.
• MGMT Promoter Methylation: Tumors with this feature respond better to temozolomide chemotherapy.
• EGFR Amplification: Often seen in glioblastomas, this suggests a more aggressive tumor.
• BRAF Alterations: Common in pediatric and some low-grade gliomas, these alterations may be treated with targeted therapies like dabrafenib and trametinib.
• CDKN2A/B Homozygous Deletion: Found in more aggressive gliomas, this indicates a poorer prognosis.

Understanding both the grade and molecular profile of a glioma allows doctors to develop more personalized treatment plans, potentially improving outcomes.

What to Expect After a Glioma Diagnosis

A glioma diagnosis can feel overwhelming, but there are important steps you can take to ensure you receive the best possible care:

1. Ask Questions: Understanding your tumor’s grade, molecular markers, and treatment options is crucial.
2. Seek Multiple Opinions: Consulting a neuro-oncologist or a major cancer center can provide additional insights.
3. Understand Treatment Options: Surgery, radiation, chemotherapy, and targeted therapies are all considerations.
4. Commit to Regular Monitoring: Follow-up MRIs and appointments are essential to track the tumor’s progression.
5. Build a Support System: Family, friends, and patient support groups can provide emotional and practical assistance.
6. Stay Informed on New Treatments: Clinical trials and ongoing research may offer new treatment possibilities.

Questions to Ask Your Doctor

If you or a loved one has been diagnosed with a glioma, here are some key questions to discuss with your doctor:

• What is the grade of my glioma?
• Have I been tested for molecular markers, and what do they mean for my treatment?
• What treatment options are available for my specific diagnosis?
• What are the possible side effects of treatment?
• How will we monitor the tumor after treatment?
• Are there any clinical trials that could be beneficial for me?
• What lifestyle changes or supportive care options can improve my quality of life?

Learn more about SurvivorNet's rigorous medical review process.

---